本页面由Tiger Trade Technology Pte. Ltd.提供服务

Madrigal Pharmaceuticals, Inc.

602.83
+11.812.00%
盘后602.830.00000.00%19:44 EST
成交量:32.95万
成交额:1.98亿
市值:136.91亿
市盈率:-46.25
高:609.98
开:585.21
低:585.21
收:591.02
52周最高:609.98
52周最低:265.00
股本:2,271.14万
流通股本:1,100.01万
量比:0.80
换手率:3.00%
股息:- -
股息率:- -
每股收益(TTM):-13.0355
每股收益(LYR):-21.9007
净资产收益率:-41.22%
总资产收益率:-15.78%
市净率:21.88
市盈率(LYR):-27.53

数据加载中...

公司资料

公司名字:
Madrigal Pharmaceuticals, Inc.
交易所:
NASDAQ
成立时间:
- -
员工人数:
528
公司地址:
Four Tower Bridge,Suite 200,200 Barr Harbor Drive,West Conshohocken,Pennsylvania,United States
邮编:
19428
电话:
传真:
- -
简介:
Madrigal Pharmaceuticals, Inc.于2000年3月成立并在2001年7月开始运营。 Synta制药公司是一家生物制药公司,致力于发现、开发和商业化小分子药物以扩大和加强带有严重疾病的患者的生命,包括癌症和慢性症性疾病。该公司有两种候选药物在临床实验中用于治疗多种类型的癌症和几个用于临床前研究阶段的候选药物。所有公司的候选药物利用公司的专利、独特的化合物和集成的发现引擎发现。这家公司保留了其候选药物的全部选择权。

董事

名称
职位
Bill Sibold
President and Chief Executive Officer and Director
Julian C. Baker
Independent Chairman of the Board and Independent Director
Jacqualyn A. Fouse
Independent Director
James M. Daly
Independent Director
Kenneth M. Bate
Independent Director
Paul A. Friedman
Independent Director
Raymond Cheong
Independent Director
Richard S. Levy
Independent Director
Rebecca Taub
Director

股东

名称
职位
Bill Sibold
President and Chief Executive Officer and Director
Mardi Dier
Executive Vice President and Chief Financial Officer
Rita Thakkar
Senior Vice President and Chief Accounting Officer
Carole Huntsman
Executive Vice President and Chief Commercial Officer
David Soergel
Executive Vice President and Chief Medical Officer
Shannon Kelley
Executive Vice President and Chief Legal Counsel